Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02110719 · ClinicalTrials.gov registry record · Phase 4
Decreasing Narcotics in Advanced Pelvic Surgery
A Phase 4 study, sponsored by Hartford Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 138
- Enrollment target
NCT02110719: Completed Phase 4 study, sponsored by Hartford Hospital.
NCT02110719 is a Phase 4 study that has completed, run by Hartford Hospital. The registered enrollment target is 138 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02110719, a Phase 4 study, has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 138 participants
- Enrollment target
Study Summary
In recent years, there has been an emphasis on the creation of "enhanced-recovery", "fast-track" or "multi-modal" pathways to improve perioperative care (1-4). The goal of these programs is to reduce the length of hospital stay, decrease narcotic usage while improving pain control, accelerate post-operative recovery, and expedite return to baseline functional status. Pathways often are developed by a team of surgeons, nurses, pain specialists, anesthesiologists and other support staff. Postoperative components often involve multi-modal analgesia, early return to activity and early return to a regular diet. The goal of this study is to evaluate the efficacy of a multi-modal pain regimen in advanced pelvic surgery with a primary goal of decreasing narcotic usage.
Primary Outcome
Narcotic use will be evaluated at all stages of the preoperative care: operating room, hospital floor and at the 1 week postoperative time point
Interventions
- DRUG Gabapentin
- DRUG IV acetaminophen
- DRUG Celebrex
- DRUG oral ibuprofen
- DRUG oral acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-06 |
| Phase | Phase 4 |
What the finished NCT02110719 record still lists
NCT02110719 is an interventional study that assigns participants to a tested intervention. The registered 138 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 5 interventions - of which Gabapentin is the first listed.
NCT02110719 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02110719 about?
NCT02110719 is a clinical study titled "Decreasing Narcotics in Advanced Pelvic Surgery". In recent years, there has been an emphasis on the creation of "enhanced-recovery", "fast-track" or "multi-modal" pathways to improve perioperative care (1-4). The goal of these programs is to reduce the length of hospital stay, decrease narcotic usage while improving pain control, accelerate post-o...
What is the current status of trial NCT02110719?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 138 participants. The study started on 2014-03. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02110719?
The interventions under investigation include: Gabapentin (DRUG), IV acetaminophen (DRUG), Celebrex (DRUG), oral ibuprofen (DRUG), oral acetaminophen (DRUG).
Who is sponsoring clinical trial NCT02110719?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02110719's enrollment target sits among peer trials
138 593rd of 2000 higher than 1,407 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04402788 · 138 participants · Phase 2
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
- NCT04883255 · 138 participants · Early Phase 1
Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- NCT05620784 · 138 participants · Phase 3
Intra-operative Loop Diuretics to Improve Same-day Discharge Rates After HoLEP
- NCT05832086 · 138 participants · Phase 2
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia